ECL-19

N/A

Report date: 2023/01/07 18:18:08
NME

Base Information

Drug NameECL-19
Drug Alias NameN/A
ClassificationSmall molecules
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesSwedenIndia
CombinationsNo
Global Highest StatusClinical
Highest Status in ChinaN/A
Originator CompaniesAventyn Inc
China Registration ClassN/A

Develop Information

Active CompaniesAventyn Inc
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A